title: Pseudotumor cerebri in a patient being treated for bipolar disorder.
authors.forename: Yeşim Yetimalar
authors.initials: YY
authors.lastname: Beckmann
authors.forename: Yaprak
authors.initials: Y
authors.lastname: Seçil
authors.forename: Buket Belkiz
authors.initials: BB
authors.lastname: Güngör
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects; D018692:Antimanic Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D001714:Bipolar Disorder / Q000150:complications* / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077152:Olanzapine; D017374:Paroxetine / Q000009:adverse effects; D011559:Pseudotumor Cerebri / Q000139:chemically induced / Q000150:complications* / Q000523:psychology; D014635:Valproic Acid / Q000009:adverse effects
chemical_list: D018687:Antidepressive Agents, Second-Generation; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D017374:Paroxetine; D014635:Valproic Acid; D000077152:Olanzapine